Key facts
- Notable investors include InnoSpace Thailand.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Nabsolute
- ·The full record, as it builds
Funding rounds
No funding rounds for Nabsolute are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nabsolute
Developer of a bioactive delivery system designed to enhance the efficacy and stability of active ingredients. The company platform offers a proprietary nanotechnology-based platform that improves bioavailability, reduces side effects, and extends the shelf life of cosmeceutical and pharmaceutical products, enabling the healthcare and wellness industry to create more effective and sustainable formulations.
- Sector
- Healthcare
- HQ
- Bangkok, Thailand
- Founded
- 2020
- Employees
- 20
- Website
- nabsolute.bio/
- Ownership
- Privately Held (backing)
Nabsolute doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nabsolute shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nabsolute in its N-PORT filings yet. We sweep new filings monthly.